Endocrinology, Vol 117, 2182-2189, Copyright © 1985 by Endocrine Society

ARTICLES

Subtype-selective down-regulation of rat renal cortical alpha- and beta- adrenergic receptors by catecholamines

MD Snavely, MG Ziegler and PA Insel

In the current studies, we have explored agonist-mediated down- regulation of adrenergic receptors in vivo. We infused catecholamines from sc implanted osmotic minipumps and examined the effects of the resultant increases in circulating levels of catecholamines on rat renal cortical alpha- and beta-adrenergic receptor subtypes, as assessed in radioligand binding studies. Infusion of epinephrine or norepinephrine (at 150 micrograms/kg X h) elevated plasma levels of each catecholamine 10- to 20-fold and decreased renal cortical alpha 1- receptor number about 50% without changing alpha 2-receptor number. Isoproterenol infusion (150 micrograms/kg X h) raised plasma levels of this catecholamine, but had no effect on the number of either alpha 1- or alpha 2-receptors. Renal cortical beta-adrenergic receptor number was decreased by infusion of all three catecholamines. However, the beta 1- and beta 2-adrenergic receptors were altered selectively by the different agonists. Infusion of norepinephrine decreased both beta 1- and beta 2-receptor number, but was more effective for the beta 1- receptors; this result was somewhat at variance with that we previously reported for rats bearing transplanted pheochromocytomas. The decrease in beta-receptor number due to epinephrine infusion was largely due to loss of the renal cortical beta 2-receptors. Infusion of isoproterenol decreased the number of both beta 1- and beta 2-receptors (69% and 75%, respectively). Infusion of norepinephrine maximally decreased the number of alpha 1-, beta 1-, and beta 2-receptors within 2 days, and the t 1/2 for receptor loss was about 12 h. beta-Receptors lost in response to isoproterenol infusion could not be recovered in a pellet prepared by high speed centrifugation of the supernatant derived from the preparation of renal cortical membranes. These results indicate that adrenergic receptor subtypes are differentially down-regulated by elevated levels of circulating catecholamines and that this differential loss of receptors depends on the nature of the receptor subtype, the agonist, and perhaps also whether catecholamines are infused rather than increased by pheochromocytoma.

This article has been cited by other articles:

				T. ZELINKA, K. PACAK, and J. WIDIMSKY JR Characteristics of blood pressure in pheochromocytoma. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 86 - 93. [Abstract] [Full Text] [PDF]

				E. E. Morgan, S. M. Stader, C. M. Hodnichak, K. E. Mavrich, H. G. Folkesson, and M. B. Maron Postreceptor defects in alveolar epithelial {beta}-adrenergic signaling after prolonged isoproterenol infusion Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L578 - L583. [Abstract] [Full Text] [PDF]

				J. A. Alhashemi Reduction of vasopressor requirement by hydrocortisone administration in a patient with cerebral vasospasm Br. J. Anaesth., January 1, 2001; 86(1): 138 - 141. [Abstract] [Full Text] [PDF]

				E. E. Morgan, C. M. Hodnichak, S. M. Stader, K. C. Maender, J. W. Boja, H. G. Folkesson, and M. B. Maron Alveolar Epithelial Ion and Fluid Transport: Prolonged isoproterenol infusion impairs the ability of beta 2-agonists to increase alveolar liquid clearance Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L666 - L674. [Abstract] [Full Text] [PDF]